ArticleClinical and translational science2025

Regulatory Disparities Between US Accelerated Approval and Japanese Authorization of Oncology Drugs: An Analysis of Evidence Quality.

Maho Iwata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.